SO
GYRE icon

STRS Ohio’s Gyre Therapeutics GYRE Stock Holding History

STRS Ohio’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170K Buy
25,800
+4,700
+22% +$32K ﹤0.01% 1668
2026
Q1 		$147K Hold
21,100
– – ﹤0.01% 1619
2025
Q4 		$149K Hold
21,100
– – ﹤0.01% 1664
2025
Q3 		$157K Buy
21,100
+7,800
+59% +$59.2K ﹤0.01% 1657
2025
Q2 		$97.8K Buy
+13,300
New +$116K ﹤0.01% 1872
2021
Q2 		– Sell
-893
Closed -$33K – 2314
2021
Q1 		$33K Buy
+893
New +$40.8K ﹤0.01% 2076
2018
Q3 		– Sell
-467
Closed -$37K – 2138
2018
Q2 		$40K Buy
+467
New +$81.9K ﹤0.01% 2011

Other funds holding GYRE

HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

STRS Ohio's GYRE Position: Q2 2026 in Review

STRS Ohio increased its Gyre Therapeutics (GYRE) stake by 22% in Q2 2026, buying an estimated $32K and bringing the position to 25,800 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #1668.

STRS Ohio first reported a position in GYRE in Q2 2018 and has held it in 7 quarters since. 60 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • STRS Ohio held 25,800 shares of Gyre Therapeutics worth $170K as of Q2 2026.
  • STRS Ohio bought 4,700 Gyre Therapeutics shares in Q2 2026, an estimated $32K.
  • Gyre Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1668 holding.
  • STRS Ohio first reported a position in Gyre Therapeutics in Q2 2018 and has held it in 7 quarters since.
  • 60 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.